BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19783379)

  • 1. Stereotactic body radiation therapy boost in locally advanced pancreatic cancer.
    Seo Y; Kim MS; Yoo S; Cho C; Yang K; Yoo H; Choi C; Lee D; Kim J; Kim MS; Kang H; Kim Y
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1456-61. PubMed ID: 19783379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
    Ikeda M; Ioka T; Ito Y; Yonemoto N; Nagase M; Yamao K; Miyakawa H; Ishii H; Furuse J; Sato K; Sato T; Okusaka T
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):163-9. PubMed ID: 22677367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated.
    Chuong MD; Springett GM; Freilich JM; Park CK; Weber JM; Mellon EA; Hodul PJ; Malafa MP; Meredith KL; Hoffe SE; Shridhar R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):516-22. PubMed ID: 23562768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.
    Chang DT; Schellenberg D; Shen J; Kim J; Goodman KA; Fisher GA; Ford JM; Desser T; Quon A; Koong AC
    Cancer; 2009 Feb; 115(3):665-72. PubMed ID: 19117351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma.
    Kim MS; Choi C; Yoo S; Cho C; Seo Y; Ji Y; Lee D; Hwang D; Moon S; Kim MS; Kang H
    Jpn J Clin Oncol; 2008 Oct; 38(10):695-700. PubMed ID: 18723850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer.
    Koong AC; Le QT; Ho A; Fong B; Fisher G; Cho C; Ford J; Poen J; Gibbs IC; Mehta VK; Kee S; Trueblood W; Yang G; Bastidas JA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1017-21. PubMed ID: 15001240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer.
    Koong AC; Christofferson E; Le QT; Goodman KA; Ho A; Kuo T; Ford JM; Fisher GA; Greco R; Norton J; Yang GP
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):320-3. PubMed ID: 16168826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
    Kim HM; Bang S; Park JY; Seong J; Song SY; Chung JB; Park SW
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):535-41. PubMed ID: 18828020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
    Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
    Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.
    Sudo K; Yamaguchi T; Ishihara T; Nakamura K; Shirai Y; Nakagawa A; Kawakami H; Uno T; Ito H; Saisho H
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):219-24. PubMed ID: 17189072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Body Radiation Therapy (SBRT) for lung metastases.
    Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC
    Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer.
    Mahadevan A; Jain S; Goldstein M; Miksad R; Pleskow D; Sawhney M; Brennan D; Callery M; Vollmer C
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):735-42. PubMed ID: 20171803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer.
    Choi CW; Cho CK; Yoo SY; Kim MS; Yang KM; Yoo HJ; Seo YS; Kang JK; Lee DH; Lee KH; Lee ED; Rhu SY; Choi SC; Kim MH; Kim BJ
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):147-53. PubMed ID: 18990511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of individualized stereotactic body radiotherapy of liver metastases.
    Lee MT; Kim JJ; Dinniwell R; Brierley J; Lockwood G; Wong R; Cummings B; Ringash J; Tse RV; Knox JJ; Dawson LA
    J Clin Oncol; 2009 Apr; 27(10):1585-91. PubMed ID: 19255313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.